未登录

Е

Е. В. Степанова

Gause Institute of New Antibiotics

H指数:20

被引数:1,128

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

CD44 variant exons induce chemoresistance by modulating cell death pathways

CD44变异外显子通过调控细胞死亡通路诱导化疗耐药性。

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY

IF4.3

2025-03-060

OA

Changes in mental health services in response to the COVID-19 pandemic in high-income countries: a rapid review

高收入国家应对新型冠状病毒肺炎大流行的精神卫生服务变化: 快速回顾

IF3.6

2024-02-0610

OAAI

Tumor irradiation may improve the sensitivity of liquid biopsy: The analysis of RAS/RAF mutations in plasma obtained from radiotherapy-treated rectal cancer patients

ANNALS OF ONCOLOGY

IF65.4

2021-09-010

OAAI

Metformin increases antitumor activity of MEK inhibitor binimetinib in 2D and 3D models of human metastatic melanoma cells

BIOMEDICINE & PHARMACOTHERAPY

IF7.5

2019-01-0131

OAAI

Inhibition of endoplasmic reticulum stress-induced autophagy sensitizes melanoma cells to temozolomide treatment

ONCOLOGY REPORTS

IF3.9

2018-07-0115

PREAI

Targeting FGFR2 with alofanib (RPT835) shows potent activit in tumour models (vol 61, pg 20, 2016)

EUROPEAN JOURNAL OF CANCER

IF7.1

2017-01-010

OAAI

Alofanib, an allosteric FGFR2 inhibitor, has potent effects on ovarian cancer growth in preclinical studies

INVESTIGATIONAL NEW DRUGS

IF2.7

2016-11-0317

PREAI

Riboflavin photoactivation by upconversion nanoparticles for cancer treatment

SCIENTIFIC REPORTS

IF3.9

2016-10-1293

OAAI

Targeting FGFR2 with alofanib (RPT835) shows potent activity in tumour models

EUROPEAN JOURNAL OF CANCER

IF7.1

2016-07-0128

PREAI

Detection of mutations in melanoma samples by biochip-based assay and next-generation sequencing

EUROPEAN JOURNAL OF CANCER

IF7.1

2015-09-010

PREAI

Alofanib, a novel allosteric FGFR2 inhibitor, shows potent antitumor activity in ovarian cancer with FGFR2 expression

CANCER RESEARCH

IF16.6

2015-08-010

PRE

Allosteric FGFR2 inhibitor RPT835 impacts on tumor growth and neovascularization

CANCER RESEARCH

IF16.6

2014-10-013

PRE

OM-RCA-01, a novel humanized monoclonal antibody targeting fibroblast growth factor receptor 1, in renal cell carcinoma model

INVESTIGATIONAL NEW DRUGS

IF2.7

2013-09-1318

PREAI

Microarray with LNA-probes for genotyping of polymorphic variants of Gilbert's syndrome gene UGT1A1(TA)n

CLINICAL CHEMISTRY AND LABORATORY MEDICINE

IF3.7

2012-12-158

PREAI

Antiangiogenic and antivascular effects of a recombinant tumstatin-derived peptide in a corneal neovascularization model

IF3

2012-06-0113

PREAI

The involvement of Notch signaling in melanoma vasculogenic mimicry

CLINICAL AND EXPERIMENTAL MEDICINE

IF3.5

2012-05-2542

PREAI

Synthesis and cytotoxic potency of novel tris(1-alkylindol-3-yl)methylium salts: Role of N-alkyl substituents

BIOORGANIC & MEDICINAL CHEMISTRY

IF3

2010-09-0127

PREAI

p53 hot-spot mutants increase tumor vascularization via ROS-mediated activation of the HIF1/VEGF-A pathway

IF10.1

2009-04-0181

PRE